Italy

BMI View: The sharp drop in public pharmaceutical expenditure in Italy in the first four months of 2012 serves as a warning for the continuation of a fall in spending... 2012-10-15

BMI View: The ongoing hospital debt situation, in addition to the Italian government's focus on de-reimbursement, will offset any benefits of the recently passed legislation that encourages... 2012-09-13

BMI View: The Italian pharmaceuticals and healthcare sector will be the target of further cost-containment measures in 2012, because while public hospital spending has decreased, hospitals... 2012-06-27

BMI View: We maintain our forecast of deteriorating prospects for drugmakers in Italy, as in addition to a decline in public spending on pharmaceuticals (enforced by price cuts on medicines),... 2012-06-12

BMI View: The drug markets of the EU5 countries, Germany, the UK, France, Spain and Italy, will experience a decline over the 2011-2016 forecast period. Our bearish outlook takes into... 2012-06-11

BMI View: The Italian public hospital debt situation will force the government to widen its cost-containment focus from price cuts on medicines to the implementation of suppressive... 2012-06-06

BMI View: The ability and willingness of countries to pay back debts due to pharmaceutical companies across Europe is as important as the array of drug policy reforms that are enforcing... 2012-04-13